Persistent antagonism of methamphetamine-induced dopamine release in rats pretreated with GBR12909 decanoate

Journal of Pharmacology and Experimental Therapeutics

Volumn 301, Issue 3, 2002, Pages 1190-1197

  Baumann, Michael H ^a   Ayestas, Mario A ^a   Sharpe, Lawrence G ^b   Lewis, David B ^a,b   Rice, Kenner C ^a,b   Rothman, Richard B ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DECANOIC ACID DERIVATIVE; DOPAMINE; DOPAMINE TRANSPORTER; METHAMPHETAMINE; UNCLASSIFIED DRUG; VANOXERINE; VANOXERINE DECANOATE;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; AUTORADIOGRAPHY; BINDING AFFINITY; BINDING KINETICS; CONTROLLED STUDY; DOPAMINE RELEASE; DOPAMINERGIC NERVE CELL; DRUG FORMULATION; LIMBIC CORTEX; MALE; MICRODIALYSIS; NERVE ENDING; NEUROCHEMISTRY; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; SUBSTANCE ABUSE;

ANIMALS; DOPAMINE; DOPAMINE UPTAKE INHIBITORS; INJECTIONS, INTRAVENOUS; MALE; METHAMPHETAMINE; MICRODIALYSIS; NUCLEUS ACCUMBENS; PIPERAZINES; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN;

EID: 0036264186     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.301.3.1190     Document Type: Article

References (44)

1. History of the methamphetamine problem
2. Drug abuse treatment entry and engagement: Report of a meeting on treatment readiness
3. Effects of phentermine and fenfluramine on extracellular dopamine and serotonin in rat nucleus accumbens: Therapeutic implications
4. GBR12909 attenuates cocaine-induced activation of mesolimbic dopamine neurons in the rat
5. Evaluation of phentermine and fenfluramine, alone and in combination, in normal, healthy volunteers
6. Monoamine reuptake inhibitors enhance the discriminative state induced by cocaine in the rat
7. Regulated trafficking of the human dopamine transporter
8. Dose response of prophylactic antipsychotics
9. 14C-fluphenazine enanthate and decanoate esters administered in sesame oil to dogs
10. Prolongation of the action of intramuscular formulations of phenothiazines
11. Cocaine addiction: Psychology and neurophysiology
12. Sustained decrease in cocaine-maintained responding in rhesus monkeys with 1-[2-[bis(4-fiuorophenyl)methoxy]ethyl]-4-(3-hydroxy-3-phenylpropyl) piperazinyl decanoate, a long-acting ester derivative of GBR 12909
13. Effects of GBR12909 on responding maintained under a progressive-ratio schedule of methamphetamine delivery in rhesus monkeys
14. Effects of dopamine reuptake inhibitors on food and cocaine maintained responding. II. Comparisons with other drugs and repeated administrations
15. Serotonergic manipulations both potentiate and reduce brain stimulation reward in rats: Involvement of serotonin 1A receptors
16. Psychiatric comorbidity of methamphetamine dependence in a forensic sample
17. Discriminative stimulus properties of cocaine: Enhancement by monoamine reuptake inhibitors
18. Hippocampus norepinephrine, caudate dopamine and serotonin and behavioral responses to stereoisomers of amphetamine and methamphetamine
19. Neurochemical changes in cocaine withdrawal
20. Chronic administration of the selective dopamine uptake inhibitor, GBR12909, but not cocaine, produces marked decreases in dopamine transporter density
21. Oxygenated analogs of 1-[2-(diphenylmethoxy)ethyl]- and 1-[2-[bis-(4-fluorophenyl)methoxy]ethyl] 4-(3-phenylpropyl)piperazines (GBR12935 and GBR12909) as potential extended-action cocaine-abuse therapeutic agents
22. Correlates of outpatient drug-treatment drop-out among methamphetamine users
23. Reinforcing effects of certain serotonin-releasing amphetamine derivatives
24. Pharmacokinetic and pharmacodynamic analysis of the action of amphetamine and D-methamphetamine on dopamine terminals
25. Membrane trafficking regulates the activity of the human dopamine transporter
26. Vanoxerine, National Institute on Drug Abuse
27. Evaluation of the conditioned reinforcing effects of phentermine and fenfluramine in the rat: Concordance with clinical studies
28. High affinity dopamine uptake inhibitors as potential cocaine antagonists
29. A review of the effects of dopaminergic agents on humans, animals and drug seeking behavior and its implications for medication development: Focus on GBR12909
30. GBR12909 antagonizes the ability of cocaine to elevate extracellular levels of dopamine
31. Methamphetamine dependence: Medication development efforts based on a dual deficit model of stimulant addiction
32. 125I]RTI-55 in membranes prepared from human, monkey and guinea pig caudate
33. From synapse to vesicle: The reuptake and storage of biogenic amine neurotransmitters
34. Amphetamine: Effects on catecholamine systems and behavior
35. A tolerance study of single and multiple dosing of the selective dopamine uptake inhibitor GBR 12909 in healthy subjects
36. 125I]RTI-55: In vitro binding and autoradiographic characterization
37. Effects of monoamine reuptake inhibitors on cocaine self-administration in rats
38. Differential reinforcing effects of cocaine and GBR-12909: Biochemical evidence for divergent neuroadaptive changes in the mesolimbic dopaminergic system
39. 11C]raclopride continuous infusion PET scans
40. 11C]WIN-35,428 positron emission tomography studies and direct in vitro determinations
41. Biogenic amine flux mediated by cloned transporters stably expressed in cultured cell lines: Amphetamine specificity for inhibition and efflux
42. Striatal dopamine nerve terminal markers in human chronic methamphetamine users
43. Neurobiology of addiction
44. In vivo human dopamine transporter occupancy of a potential cocaine treatment agent